Mark Butler announces Forxiga to be expanded for thousands of Australians with chronic heart failure
Thousands of Australians suffering with chronic heart failure have been thrown a new lifeline, with a potentially lifesaving medication added to the Pharmaceutical Benefits Scheme. In a move praised by cardiologists, dapagliflozin – sold by the brand name Forxiga and currently listed on the PBS to treat type two diabetesContinue Reading